Complete surgical removal of multiple tumor lesions in malignant pheochromocytomas produces a good prognosis

Malignant pheochromocytomas are rare catecholamine secreting tumors; there is no definitive strategy for the treatment of malignant pheochromocytomas, especially in cases with multiple tumors.

[1]  W. Young,et al.  Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years , 2017, The Journal of clinical endocrinology and metabolism.

[2]  Tae Yong Kim,et al.  Clinical course and prognostic factors in patients with malignant pheochromocytoma and paraganglioma: A single institution experience , 2015, Journal of surgical oncology.

[3]  A. Hernigou,et al.  Peritoneal implantation of pheochromocytoma following tumor capsule rupture during surgery. , 2014, The Journal of clinical endocrinology and metabolism.

[4]  S. Steinberg,et al.  Response after surgical resection of metastatic pheochromocytoma and paraganglioma: can postoperative biochemical remission be predicted? , 2013, Journal of the American College of Surgeons.

[5]  P. Levillain,et al.  Malignant pheochromocytoma: new malignancy criteria , 2012, Langenbeck's Archives of Surgery.

[6]  A. Harari,et al.  Malignant pheochromocytoma: a review. , 2011, American journal of surgery.

[7]  Herb Chen,et al.  Pheochromocytoma: current approaches and future directions. , 2008, The oncologist.

[8]  L. Thompson.  Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms: A Clinicopathologic and Immunophenotypic Study of 100 Cases , 2002, The American journal of surgical pathology.

[9]  P. Dicpinigaitis,et al.  Hypertensive crises induced by treatment of malignant pheochromocytoma with a combination of cyclophosphamide, vincristine, and dacarbazine. , 1994, Medical and pediatric oncology.